SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JSB who wrote (419)11/17/1998 12:04:00 PM
From: Street Walker  Read Replies (1) of 90042
 
DEPO FDA approval pending

DEPO is being bought out in March 2000
The exact buyout price has not been set.

The buy-out price depends upon various milestones achieved.
With each milestone achieved, the buy-out price goes higher.

FDA approval is one of the milestones.

The buyout price you mentioned is if no milestones are reached.
Each milestone achieved, makes the buy-out price go higher and higher.
As the value of the buyout shares increase in value over the next year and a half.

Regards,
S.W.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News